THR-0921

CAS No. 606932-81-4

THR-0921( —— )

Catalog No. M36271 CAS No. 606932-81-4

THR-0921 (CLX-0921) is a peroxisome proliferator-activated receptor (PPAR) agonist that can be used to study cardiovascular and metabolic diseases.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 547 In Stock
10MG 758 In Stock
25MG 1121 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    THR-0921
  • Note
    Research use only, not for human use.
  • Brief Description
    THR-0921 (CLX-0921) is a peroxisome proliferator-activated receptor (PPAR) agonist that can be used to study cardiovascular and metabolic diseases.
  • Description
    THR-0921 (CLX-0921) is a peroxisome proliferator-activated receptor (PPAR) agonist that can be used to study cardiovascular and metabolic diseases.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    PPAR
  • Recptor
    PPAR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    606932-81-4
  • Formula Weight
    519.57
  • Molecular Formula
    C28H25NO7S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(=C/C1=CC(OC)=CC(OC)=C1)(\C(OC)=O)/C2=CC=C(OC3=CC=C(CC4SC(=O)NC4=O)C=C3)C=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Lonazolac

    Lonazolac is a nonsteroidal anti-inflammatory drug.

  • Saroglitazar

    A novel PPAR agonist with predominant PPARα and moderate PPARγ activity with EC50 of 0.65 pM and 3 nM respectively.

  • Reglitazar

    Reglitazar (JTT-501) is a dual PPARα and PPARγ agonist that is used to study diabetes.